应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NGNE NEUROGENE INC
盘后交易 05-14 16:47:27 EDT
31.55
+0.91
+2.97%
盘后
30.64
-0.91
-2.88%
16:22 EDT
最高
31.73
最低
29.57
成交量
8.30万
今开
30.32
昨收
30.64
日振幅
7.05%
总市值
4.06亿
流通市值
1.99亿
总股本
1,287万
成交额
252.62万
换手率
1.32%
流通股本
629.88万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-Akoya Biosciences、波士顿啤酒公司、胜利资本控股公司
Reuters · 05-14 15:22
美国研究综述-Akoya Biosciences、波士顿啤酒公司、胜利资本控股公司
Neurogene Inc 预计每股亏损 1.14 美元 - 财报前瞻
Reuters · 05-04
Neurogene Inc 预计每股亏损 1.14 美元 - 财报前瞻
加载更多
公司概况
公司名称:
NEUROGENE INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Neurogene Inc.前身为6175813加拿大公司(6175813 Canada Inc.)。该公司根据加拿大商业公司法,于2003年12月26日注册成立。Neurogene的使命是治疗毁灭性的神经系统疾病,以改善受这些罕见疾病影响的患者和家庭的生活。Neurogene正在开发新的方法和治疗方法,以解决传统基因疗法在中枢神经系统疾病中的局限性。这包括选择一种递送方法以最大限度地分配到目标组织,并设计产品以最大限度地提高效力和纯度,以实现优化的功效和安全性。Neurogene的新型专有EXACT转基因调控平台技术允许传递治疗水平,同时限制与常规基因治疗相关的转基因毒性。Neurogene在德克萨斯州休斯顿建造了一座最先进的基因疗法制造设施。
发行价格:
--
{"stockData":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":31.55,"timestamp":1715716800000,"preClose":30.64,"halted":0,"volume":82957,"hourTrading":{"tag":"盘后","latestPrice":30.64,"preClose":31.55,"latestTime":"16:22 EDT","volume":250,"amount":7885.67975,"timestamp":1715718138347},"delay":0,"floatShares":6298833,"shares":12865684,"eps":1.026155,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.91,"latestTime":"05-14 16:47:27 EDT","open":30.32,"high":31.73,"low":29.57,"amount":2526217.597281,"amplitude":0.070496,"askPrice":34.58,"askSize":100,"bidPrice":28.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.026155,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715731200000},"adr":0,"listingDate":1394168400000,"adjPreClose":30.64,"postHourTrading":{"tag":"盘后","latestPrice":30.64,"preClose":31.55,"latestTime":"16:22 EDT","volume":250,"amount":7885.67975,"timestamp":1715718138347},"volumeRatio":1.729352},"requestUrl":"/m/hq/s/NGNE","defaultTab":"news","newsList":[{"id":"2435568188","title":"美国研究综述-Akoya Biosciences、波士顿啤酒公司、胜利资本控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2435568188","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435568188?lang=zh_cn&edition=full","pubTime":"2024-05-14 15:22","pubTimestamp":1715671336,"startTime":"0","endTime":"0","summary":" 路透5月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Akoya Biosciences、波士顿啤酒公司和 Victory Capital Holdings。要点 * Akoya Biosciences Inc :Canaccord Genuity将目标价从10美元下调至6美元 * 波士顿啤酒公司 :杰富瑞将目标价从335美元上调至360美元 * Fortrea Holdings Inc :Evercore ISI将目标价从43美元下调至31美元 * Medical Properties Trust Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432558781","title":"Neurogene Inc 预计每股亏损 1.14 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432558781","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432558781?lang=zh_cn&edition=full","pubTime":"2024-05-04 06:16","pubTimestamp":1714774585,"startTime":"0","endTime":"0","summary":" * Neurogene Inc 预计在5月6日公布截至2024年3月31日的财报时,季度收入将没有变化(预计) * * LSEG 的分析师平均预计 Neurogene Inc 每股亏损 1.14 美元。* 华尔街对 Neurogene Inc 的 12 个月目标价中位数为 46.00 美元,高于其最新收盘价 36.63 美元。5月3日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurogene.com","stockEarnings":[{"period":"1week","weight":-0.0661},{"period":"1month","weight":-0.2282},{"period":"3month","weight":0.0244},{"period":"6month","weight":1.2203},{"period":"1year","weight":0.7409},{"period":"ytd","weight":0.581}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.1584},{"period":"1year","weight":0.2656},{"period":"ytd","weight":0.0959}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neurogene Inc.前身为6175813加拿大公司(6175813 Canada Inc.)。该公司根据加拿大商业公司法,于2003年12月26日注册成立。Neurogene的使命是治疗毁灭性的神经系统疾病,以改善受这些罕见疾病影响的患者和家庭的生活。Neurogene正在开发新的方法和治疗方法,以解决传统基因疗法在中枢神经系统疾病中的局限性。这包括选择一种递送方法以最大限度地分配到目标组织,并设计产品以最大限度地提高效力和纯度,以实现优化的功效和安全性。Neurogene的新型专有EXACT转基因调控平台技术允许传递治疗水平,同时限制与常规基因治疗相关的转基因毒性。Neurogene在德克萨斯州休斯顿建造了一座最先进的基因疗法制造设施。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.087633},{"month":2,"riseRate":0.3,"avgChangeRate":-0.066901},{"month":3,"riseRate":0.5,"avgChangeRate":0.07464},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.109442},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.029551},{"month":6,"riseRate":0.5,"avgChangeRate":-0.071354},{"month":7,"riseRate":0.4,"avgChangeRate":-0.124709},{"month":8,"riseRate":1,"avgChangeRate":0.955979},{"month":9,"riseRate":0.2,"avgChangeRate":-0.084307},{"month":10,"riseRate":0.3,"avgChangeRate":-0.078191},{"month":11,"riseRate":0.5,"avgChangeRate":0.080718},{"month":12,"riseRate":0.7,"avgChangeRate":0.189368}],"exchange":"NASDAQ","name":"NEUROGENE INC","nameEN":"NEUROGENE INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NEUROGENE INC,NGNE,NEUROGENE INC股票,NEUROGENE INC股票老虎,NEUROGENE INC股票老虎国际,NEUROGENE INC行情,NEUROGENE INC股票行情,NEUROGENE INC股价,NEUROGENE INC股市,NEUROGENE INC股票价格,NEUROGENE INC股票交易,NEUROGENE INC股票购买,NEUROGENE INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NEUROGENE INC(NGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NEUROGENE INC(NGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}